What are the treatment options for sinus issues?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Sinus Issues

For acute bacterial sinusitis, amoxicillin or amoxicillin-clavulanate (875 mg twice daily) is the first-line antibiotic treatment for 7-10 days, combined with intranasal corticosteroids to reduce inflammation and promote drainage. 1

Initial Assessment and Diagnosis

Before initiating treatment, confirm the diagnosis based on specific clinical criteria:

  • Persistent symptoms (nasal discharge, congestion, facial pain, or cough) lasting >10 days without improvement 2
  • Severe symptoms including high fever (>39°C) and purulent nasal discharge for 3-4 consecutive days 2
  • Worsening symptoms after initial improvement from a viral upper respiratory infection 2
  • Unilateral infraorbital pain that worsens when bending forward, often pulsatile and peaking in evening/night for maxillary sinusitis 3

Imaging is not required for uncomplicated acute sinusitis but should be considered if symptoms persist beyond 21-28 days or complications are suspected. 3, 4

First-Line Antibiotic Treatment

Standard Therapy for Adults

Amoxicillin is the preferred initial choice: 1

  • Mild disease: 500 mg twice daily
  • Moderate-severe disease: 875 mg twice daily
  • Duration: 7-10 days (treat until symptom-free for 7 days) 3, 1

Amoxicillin-clavulanate (875 mg/125 mg twice daily) should be used for: 1

  • Patients with recent antibiotic exposure (within 4-6 weeks)
  • More severe infections
  • Areas with high prevalence of resistant Streptococcus pneumoniae
  • Treatment failure after 3-5 days of amoxicillin 3, 1

Penicillin-Allergic Patients

For documented penicillin allergy, use: 1

  • Second-generation cephalosporins: Cefuroxime-axetil 3, 1
  • Third-generation cephalosporins: Cefpodoxime-proxetil, cefdinir, or cefotiam-hexetil 3, 1
  • Pristinamycin for true beta-lactam allergy 3

Critical pitfall: Do NOT use azithromycin or other macrolides due to 20-25% resistance rates in S. pneumoniae and H. influenzae. 1

Treatment Based on Anatomic Location

Maxillary sinusitis (most common): Standard first-line antibiotics as above 3, 1

Frontal, ethmoidal, or sphenoidal sinusitis require more aggressive therapy due to risk of serious complications: 3, 1

  • Fluoroquinolones: Levofloxacin or moxifloxacin should be considered first-line for these locations 3, 1
  • These sites have higher risk of intracranial complications and warrant closer monitoring 3

Adjunctive Therapies (Essential Components)

Intranasal Corticosteroids

Strongly recommended as adjunct to antibiotics in both acute and chronic sinusitis: 1

  • Reduces mucosal inflammation and edema
  • Promotes sinus drainage and ostial patency
  • Examples: Fluticasone propionate 1-2 sprays per nostril daily 5
  • Can be continued long-term for maintenance in recurrent cases 3

Supportive Measures

All patients should receive: 1

  • Adequate hydration (increases mucus fluidity)
  • Analgesics for pain control
  • Warm facial compresses over affected sinuses
  • Sleep with head elevated to promote drainage
  • Oral decongestants (pseudoephedrine) to decrease nasal resistance 6
  • Saline nasal irrigation to mechanically clear secretions

Short-term Oral Corticosteroids

Consider for: 1

  • Marked mucosal edema on examination
  • Severe pain (acute hyperalgic sinusitis) - dexamethasone 4 mg can be used 1
  • Failure to respond to initial antibiotic therapy after 3-5 days 3, 1

Important: Oral corticosteroids should only be used as short-term adjunctive therapy, never as monotherapy for bacterial sinusitis. 1

Treatment Failure Protocol

Reassess at 3-5 Days

If no improvement after initial therapy: 3, 1

Switch to second-line antibiotics: 1

  • High-dose amoxicillin-clavulanate (if not already used)
  • Cefuroxime or cefpodoxime
  • Respiratory fluoroquinolones (levofloxacin 500-750 mg daily or moxifloxacin 400 mg daily) 3, 1

Partial Response (Improved but Not Resolved)

  • Continue current antibiotic for additional 10-14 days 3
  • Add or optimize intranasal corticosteroids 1
  • Consider short course of oral corticosteroids 3

Poor Response (Little to No Improvement)

After 21-28 days of treatment: 3

  • Consider broader-spectrum coverage with anaerobic agents (add clindamycin or metronidazole) 3
  • Obtain CT scan to evaluate for complications, anatomic abnormalities, or alternative diagnoses 3
  • Refer to otolaryngology or allergy/immunology 3

Pediatric Dosing

Amoxicillin: 1

  • Standard: 45 mg/kg/day in 2 divided doses
  • High-dose: 80-90 mg/kg/day in 2 divided doses (for resistant S. pneumoniae)

Amoxicillin-clavulanate: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1

For penicillin allergy: Cefpodoxime proxetil 8 mg/kg/day in 2 doses 1

Chronic Sinusitis (Symptoms ≥8 Weeks)

This represents a different disease process: 3

  • Consider non-infectious etiology: Chronic hyperplastic eosinophilic rhinosinusitis does not respond to antibiotics 3
  • Systemic corticosteroids may be required for eosinophilic disease 3
  • Evaluate underlying factors: 3
    • Allergic rhinitis (test for IgE sensitization to inhalants) 3
    • Immunodeficiency (measure IgG, IgA, IgM levels; assess antibody responses) 3
    • Anatomic abnormalities (septal deviation, polyps, ostiomeatal obstruction) 3
    • Gastroesophageal reflux disease 3
  • CT imaging is indicated to define extent of disease and anatomy 3
  • Functional endoscopic sinus surgery may be needed if medical management fails 3

When to Refer to Specialist

Immediate referral for: 3

  • Signs of complications (meningeal signs, exophthalmos, palpebral edema, ocular mobility disorders, severe unrelenting pain) 3
  • Frontal, ethmoidal, or sphenoidal sinusitis with poor response 3

Routine referral for: 3, 1

  • Recurrent sinusitis (≥3 episodes per year) 3
  • Chronic sinusitis refractory to 21-28 days of appropriate antibiotics 3, 1
  • Suspected immunodeficiency (recurrent sinusitis with otitis media, bronchitis, pneumonia) 3
  • Nasal polyps after trial of oral corticosteroids 3
  • Need for allergy evaluation and immunotherapy 3

Critical Pitfalls to Avoid

  • Do not use macrolides (azithromycin, clarithromycin) as first-line therapy due to high resistance rates 1
  • Reserve fluoroquinolones for treatment failures or complicated sinusitis (frontal/ethmoidal/sphenoidal) to prevent resistance 3, 1
  • Ensure adequate treatment duration - minimum 7-10 days; incomplete courses lead to relapse 3, 1
  • Do not use oral corticosteroids alone for bacterial sinusitis - always combine with antibiotics 1
  • Reassess if no improvement by 3-5 days - do not continue ineffective therapy 3, 1
  • Consider underlying allergic rhinitis in 40-60% of sinusitis patients - treat concurrently with antihistamines and intranasal corticosteroids 3, 7

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Radiologic imaging in the management of sinusitis.

American family physician, 2002

Guideline

Treatment of Right Mastoid Effusion and Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps.

The Journal of allergy and clinical immunology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.